Menu
GeneBe

rs201478459

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_144670.6(A2ML1):c.3878A>G(p.Asn1293Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000753 in 1,614,238 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00077 ( 1 hom. )

Consequence

A2ML1
NM_144670.6 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0170
Variant links:
Genes affected
A2ML1 (HGNC:23336): (alpha-2-macroglobulin like 1) This gene encodes a member of the alpha-macroglobulin superfamily. The encoded protein is thought to be an N-glycosylated monomeric protein that acts as an inhibitor of several proteases. It has been shown to form covalent interactions with proteases, and has been reported as the p170 antigen recognized by autoantibodies in the autoimmune disease paraneoplastic pemphigus (PNP; PMID:20805888). Mutations in these gene have also been associated with some cases of Noonan syndrome (NS; PMID:24939586) as well as some cases of otitis media (PMID:26121085). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008113742).
BP6
Variant 12-8868002-A-G is Benign according to our data. Variant chr12-8868002-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 413821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-8868002-A-G is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd at 88 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
A2ML1NM_144670.6 linkuse as main transcriptc.3878A>G p.Asn1293Ser missense_variant 30/36 ENST00000299698.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
A2ML1ENST00000299698.12 linkuse as main transcriptc.3878A>G p.Asn1293Ser missense_variant 30/361 NM_144670.6 P1A8K2U0-1
ENST00000631830.1 linkuse as main transcriptn.322-9726T>C intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.000578
AC:
88
AN:
152226
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000808
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000581
AC:
145
AN:
249424
Hom.:
0
AF XY:
0.000576
AC XY:
78
AN XY:
135300
show subpopulations
Gnomad AFR exome
AF:
0.000129
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.000974
Gnomad NFE exome
AF:
0.000910
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000771
AC:
1127
AN:
1461894
Hom.:
1
Cov.:
37
AF XY:
0.000763
AC XY:
555
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.000693
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.000749
Gnomad4 NFE exome
AF:
0.000907
Gnomad4 OTH exome
AF:
0.000613
GnomAD4 genome
AF:
0.000578
AC:
88
AN:
152344
Hom.:
0
Cov.:
33
AF XY:
0.000577
AC XY:
43
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.000192
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00122
Gnomad4 NFE
AF:
0.000808
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000699
Hom.:
0
Bravo
AF:
0.000578
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00120
AC:
10
ExAC
AF:
0.000579
AC:
70
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.000652

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 13, 2024- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxSep 16, 2019This variant is associated with the following publications: (PMID: 24939586) -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 21, 2019Variant summary: A2ML1 c.3878A>G (p.Asn1293Ser) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00058 in 249424 control chromosomes, predominantly at a frequency of 0.00091 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 228 fold of the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome phenotype (4e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. To our knowledge, no occurrence of c.3878A>G in individuals affected with Noonan Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -
A2ML1-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesAug 10, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.73
Cadd
Benign
0.014
Dann
Benign
0.69
DEOGEN2
Benign
0.0026
T;T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.052
N
LIST_S2
Benign
0.52
T;T;T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.0081
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
L;.;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-0.66
N;N;N
REVEL
Benign
0.0080
Sift
Benign
0.17
T;T;T
Sift4G
Benign
0.54
T;T;T
Polyphen
0.0020
B;.;.
Vest4
0.027
MVP
0.048
MPC
0.083
ClinPred
0.0014
T
GERP RS
-3.0
Varity_R
0.024
gMVP
0.055

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201478459; hg19: chr12-9020598; API